Yifeng Pharmacy603939
▲ PositiveCapitalrelevance
Company announces share buyback of 200-300 million yuan, a capital allocation event that typically supports stock price.

Yifeng Pharmacy announced plans to repurchase shares through centralized bidding, with the buyback amount set at no less than 200 million yuan and no more than 300 million yuan. The maximum repurchase price is 30.56 yuan per share, and the buyback period will not exceed six months from the date of board approval. In the first quarter of 2026, the company reported revenue of 6.085 billion yuan and net profit attributable to the parent company of 500 million yuan.
Yifeng PharmacyCompany announces share buyback of 200-300 million yuan, a capital allocation event that typically supports stock price.